A clinical observation to study the safety of Sidhha medicine- Arumuga Chenduram.
Phase 2
- Conditions
- Health Condition 1: M199- Osteoarthritis, unspecified site
- Registration Number
- CTRI/2020/08/026988
- Lead Sponsor
- Ayothidoss pandithar hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients who taking herbo mineral drug arumuga chenduram for 48 days
Exclusion Criteria
PREGNANCY
Lactation
Patients with renal and liver disease
Patients with cardiovascular disease
Patients with gastric or peptic ulcer and GERD
Patients with frequent flatulence and indigestion
History of major systemic illness
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess any changes in blood parameters and clinical symptoms during treatment, <br/ ><br>To analysis presence of mercury and iron level in bloodTimepoint: 6months
- Secondary Outcome Measures
Name Time Method Toassess any changes in blood parameters and clinical symptoms during treatment <br/ ><br>To analysis iron and mercury level in bloodTimepoint: 6 months